Trending Stories


From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.

CardioFlux Magnetocardiograph Case Studies

Partner News | Published: Wednesday, January 6, 2021

Magnetocardiography (MCG) has been assessed over the last 30 years as a rapid diagnostic tool for various forms of cardiac pathophysiology. MCG is able to detect and discern miniscule differences in the magnetic fields generated by the heart’s natural pacemaker activity. These fields have previously been shown to change with cardiac ischemia due to dysfunction of the ion channels responsible for repolarization and depolarization of the myocardium.


4 things to consider as you implement your Cardiovascular outmigration strategy

Partner News | Published: Wednesday, December 16, 2020

By Marc Toth, Vice President of Cardiovascular Services, Atlas Healthcare Partners and Meredith Banasiak, EDAC, Director of Research, Boulder Associates, Inc. It is anticipated that by 2030, 82% of all

FDA Awards Genetesis Breakthrough Device Designation for CardioFlux® Imaging Technology

Partner News | Published: Tuesday, December 15, 2020

Genetesis, Inc., a MedAxiom partner, announced today that its flagship product, CardioFlux®, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for the

Jim Andrews Appointed to Biome Analytics Board

Partner News | Published: Tuesday, December 8, 2020

Biome Analytics, the leading cardiovascular performance company announced that they have expanded the Board of Directors with the appointment of Jim Andrews. Andrews is currently senior vice president,

From Sleep Apnea Diagnosis to Treatment in Less Than Two Weeks on Average

Partner News | Published: Monday, December 7, 2020

The link between moderate-to-severe sleep apnea (SA) and serious cardiovascular disease (CVD) has been broadly accepted. Undiagnosed sleep apnea is a major comorbidity of CVD and a significant risk factor for atrial fibrillation, stroke, congestive heart failure, and hypertension.


Varsity Healthcare Partners Completes Growth Capital Investment with Partners First Cardiology

Partner News | Published: Monday, November 30, 2020

Varsity Healthcare Partners (“VHP”), a leading healthcare services private equity investment firm, announced a growth equity investment with Partners First Cardiology (“Partners First”, “PFC”, or “the Company”).


MedAxiom Announces Industry Partnership with Partners First Cardiology

Partner News | Published: Thursday, November 19, 2020

Partners First Cardiology, a physician practice Management Services Organization (MSO) that has a practice management solution designed exclusively for cardiologists.


MedAxiom Announces Industry Partnership with Atlas Healthcare Partners

Partner News | Published: Monday, November 16, 2020

Atlas Healthcare Partners, a professional management team with significant experience operating successful ambulatory surgery center (ASC) partnerships.


Bracco Diagnostics gains FDA approval for updated CardioGen-82 infusion system

Partner News | Published: Wednesday, October 21, 2020

Bracco Diagnostics announced Friday, Oct. 16, that its new CardioGen-82 infusion system for cardiac PET myocardial perfusion imaging (MPI) has received FDA approval. This new infusion system, which replaces

HEART FAILURE, SLEEP APNEA and the WATCHPAT TurnKey: A Heart Specialist’s Point of View

Partner News | Published: Tuesday, October 13, 2020

Cardiac Sleep Review (CSR) talks with Daniel Bensimhon, MD, Medical Director of The Advanced Heart and Mechanical Circulatory Support Program at Moses Cone Memorial Hospital in Greensboro, NC. Dr. Bensimhon is an Advanced Heart Failure cardiologist who treats patients with all levels of heart failure—from very mild (Class II) to patients who need full mechanical support and referral for cardiac transplantation (Class IV).